COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Allen Richon

Dr. Allen Richon

Scientific Review Officer


Division of Basic and Integrative Biological Sciences DBIB
Interdisciplinary Molecular Sciences and Training IMST
Study Section:
Small Business: Computational, Modeling, and Biodata Management IMST 14

Dr. Allen Richon received his Ph.D. in organic chemistry at The University of North Carolina at Chapel Hill, where his research focused on the synthesis of optically active natural products.

Subsequently, he completed postdoctoral training in the synthesis of complex natural products at Stanford University. He then began his career in drug discovery and development at Ciba-Geigy Pharmaceuticals, where he was a medicinal and computational chemist with research interests in cardiovascular and metabolic diseases. He also led the development of research information systems at Ciba-Geigy and subsequently at Glaxo Pharmaceuticals. Dr. Richon has also held positions at Tripos Associates, where he served as the director of training and consulting; MetaPhore Pharmaceuticals, where he served as business development officer; and LeadScope, Inc., where he was the Chief Executive Officer. Prior to joining CSR, he was the owner of an independent pharmaceutical R&D consulting firm.